Active-ingredient Dossier
Raloxifene Hydrochloride
Active-ingredient Dossier for Raloxifene Hydrochloride (selective estrogen receptor modulator). Australian brands, products, PBS listings, PBAC outcomes…
- Brand: EVISTA
- Brand: FIXTA
- Brand: RALOVISTA
- Brand: Raloxifene
- Brand: APOTEX-RALOXIFENE
- Brand: AURO-RALOXIFENE
- Therapeutic area: Endocrinology
- Therapeutic area: Musculoskeletal
What is
Raloxifene Hydrochloride Raloxifene Hydrochloride is a selective estrogen receptor modulator.
Australian brands containing
Raloxifene Hydrochloride — EVISTA — FIXTA — RALOVISTA — Raloxifene — APOTEX-RALOXIFENE — AURO-RALOXIFENE — ESTOCAL — RALOFEXA
Therapeutic areas
Raloxifene Hydrochloride is registered in oncology (10 brands) and musculoskeletal (1 brand) therapeutic areas.
Sponsor landscape
Six sponsors market raloxifene hydrochloride in Australia: Arrotex Pharmaceuticals, MedTAS, Boucher & Muir, Strides Pharma Science, Generic Health, and GM Pharma.
PBS and regulatory activity
One brand containing raloxifene hydrochloride has PBS-listed items, with the latest PBS schedule date of 1 May 2026.